JP2025013879A5 - - Google Patents

Download PDF

Info

Publication number
JP2025013879A5
JP2025013879A5 JP2024182444A JP2024182444A JP2025013879A5 JP 2025013879 A5 JP2025013879 A5 JP 2025013879A5 JP 2024182444 A JP2024182444 A JP 2024182444A JP 2024182444 A JP2024182444 A JP 2024182444A JP 2025013879 A5 JP2025013879 A5 JP 2025013879A5
Authority
JP
Japan
Prior art keywords
foxp3
locus
nucleotide sequence
homology
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024182444A
Other languages
English (en)
Japanese (ja)
Other versions
JP7844581B2 (ja
JP2025013879A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/029159 external-priority patent/WO2019210078A1/en
Application filed filed Critical
Publication of JP2025013879A publication Critical patent/JP2025013879A/ja
Publication of JP2025013879A5 publication Critical patent/JP2025013879A5/ja
Priority to JP2026059991A priority Critical patent/JP2026099845A/ja
Application granted granted Critical
Publication of JP7844581B2 publication Critical patent/JP7844581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024182444A 2018-04-27 2024-10-18 遺伝子編集t細胞におけるヒトfoxp3の発現 Active JP7844581B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026059991A JP2026099845A (ja) 2018-04-27 2026-04-01 遺伝子編集t細胞におけるヒトfoxp3の発現

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862663561P 2018-04-27 2018-04-27
US62/663,561 2018-04-27
US201862773414P 2018-11-30 2018-11-30
US62/773,414 2018-11-30
PCT/US2019/029159 WO2019210078A1 (en) 2018-04-27 2019-04-25 Expression of human foxp3 in gene edited t cells
JP2020560338A JP7575949B2 (ja) 2018-04-27 2019-04-25 遺伝子編集t細胞におけるヒトfoxp3の発現

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020560338A Division JP7575949B2 (ja) 2018-04-27 2019-04-25 遺伝子編集t細胞におけるヒトfoxp3の発現

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026059991A Division JP2026099845A (ja) 2018-04-27 2026-04-01 遺伝子編集t細胞におけるヒトfoxp3の発現

Publications (3)

Publication Number Publication Date
JP2025013879A JP2025013879A (ja) 2025-01-28
JP2025013879A5 true JP2025013879A5 (cg-RX-API-DMAC7.html) 2025-04-10
JP7844581B2 JP7844581B2 (ja) 2026-04-13

Family

ID=68295504

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020560338A Active JP7575949B2 (ja) 2018-04-27 2019-04-25 遺伝子編集t細胞におけるヒトfoxp3の発現
JP2024182444A Active JP7844581B2 (ja) 2018-04-27 2024-10-18 遺伝子編集t細胞におけるヒトfoxp3の発現
JP2026059991A Pending JP2026099845A (ja) 2018-04-27 2026-04-01 遺伝子編集t細胞におけるヒトfoxp3の発現

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020560338A Active JP7575949B2 (ja) 2018-04-27 2019-04-25 遺伝子編集t細胞におけるヒトfoxp3の発現

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026059991A Pending JP2026099845A (ja) 2018-04-27 2026-04-01 遺伝子編集t細胞におけるヒトfoxp3の発現

Country Status (10)

Country Link
US (1) US20210253652A1 (cg-RX-API-DMAC7.html)
EP (1) EP3784689A4 (cg-RX-API-DMAC7.html)
JP (3) JP7575949B2 (cg-RX-API-DMAC7.html)
KR (1) KR102912481B1 (cg-RX-API-DMAC7.html)
CN (1) CN112041334A (cg-RX-API-DMAC7.html)
AU (2) AU2019257708B2 (cg-RX-API-DMAC7.html)
CA (1) CA3091491A1 (cg-RX-API-DMAC7.html)
IL (1) IL277036A (cg-RX-API-DMAC7.html)
SG (1) SG11202007877SA (cg-RX-API-DMAC7.html)
WO (1) WO2019210078A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3042179A1 (en) 2016-10-31 2018-05-03 Seattle Children's Hospital (dba Seattle Children's Research Institute) Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene
SG11202007878UA (en) 2018-04-27 2020-09-29 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Expression of foxp3 in edited cd34+ cells
WO2020161122A1 (en) * 2019-02-05 2020-08-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Recombinant vectors suitable for the treatment of ipex syndrome
JP2022533713A (ja) * 2019-05-21 2022-07-25 サンガモ セラピューティクス, インコーポレイテッド 調節性t細胞における制御された導入遺伝子発現
CA3160113A1 (en) * 2019-11-08 2021-05-14 Sangamo Therapeutics, Inc. Generation of engineered regulatory t cells
EP4103591A4 (en) * 2020-02-13 2024-09-04 The Board of Trustees of the Leland Stanford Junior University Crispr-based foxp3 gene engineered t cells and hematopoietic stem cell precursors to treat ipex syndrome patients
IL302591A (en) * 2020-11-09 2023-07-01 Quell Therapeutics Ltd Method for cryopreservation of transgenic regulatory T cells
WO2022266139A2 (en) * 2021-06-14 2022-12-22 Graphite Bio, Inc. Methods to genetically engineer hematopoietic stem and progenitor cells for red cell specific expression of therapeutic proteins
WO2023122099A2 (en) * 2021-12-21 2023-06-29 The Board Of Trustees Of The Leland Stanford Junior University Crispr-based gene editing to preserve splicing and expression of foxp3 isoforms 1 and 2
CN115305237B (zh) * 2022-07-08 2023-07-14 中南大学 一种优化的调节性t细胞的扩增及规模化生产的方法
WO2024127369A1 (en) * 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target foxp3 gene and methods of use
CN121532517A (zh) * 2023-06-24 2026-02-13 索诺玛生物治疗公司 用于对细胞进行工程改造的组合物和方法
CN122055438A (zh) * 2023-09-08 2026-05-15 索诺玛生物治疗公司 异位表达foxp3的细胞
JP7818147B1 (ja) * 2025-01-23 2026-02-20 国立研究開発法人国立がん研究センター エフェクターt細胞、およびそれを含む医薬組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110123502A1 (en) 2007-02-21 2011-05-26 Barry Simon C Method for obtaining treg-cells
JP6608807B2 (ja) * 2013-05-29 2019-11-20 セレクティス Rnaガイドcasヌクレアーゼ系を用いることによって免疫療法のためにt細胞を操作するための方法
US20190388469A1 (en) 2015-01-30 2019-12-26 The Regents Of The University Of California Protein delivery in primary hematopoietic cells
EP3294342A4 (en) * 2015-05-08 2018-11-07 President and Fellows of Harvard College Universal donor stem cells and related methods
EP3500696A4 (en) 2016-08-16 2020-04-08 Bluebird Bio, Inc. VARIANTS OF IL-10 ALPHA RECEPTOR HOMING ENDONUCLEASE, COMPOSITIONS AND METHODS OF USE
WO2018073391A1 (en) * 2016-10-19 2018-04-26 Cellectis Targeted gene insertion for improved immune cells therapy
EP3532075A4 (en) * 2016-10-27 2020-07-08 Intima Bioscience, Inc. VIRAL METHODS OF MANUFACTURING GENETICALLY MODIFIED CELLS
CA3042179A1 (en) 2016-10-31 2018-05-03 Seattle Children's Hospital (dba Seattle Children's Research Institute) Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene
CN109790518A (zh) * 2017-05-08 2019-05-21 中国科学院动物研究所 经修饰的t细胞、其制备方法及用途
WO2019040655A1 (en) * 2017-08-22 2019-02-28 The Regents Of The University Of California LENTIVIRAL VECTORS EXPRESSING FOXP3 IN HEMATOPOIETIC STEM CELLS TO TREAT IMMUNITY DEFICIENCIES AND AUTOIMMUNE DISEASES
SG11202007878UA (en) * 2018-04-27 2020-09-29 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Expression of foxp3 in edited cd34+ cells

Similar Documents

Publication Publication Date Title
JP2025013884A5 (cg-RX-API-DMAC7.html)
JP2021526853A5 (cg-RX-API-DMAC7.html)
Gao et al. Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
JP2020518276A5 (cg-RX-API-DMAC7.html)
JP7844582B2 (ja) 遺伝子編集されたcd34+細胞におけるfoxp3の発現
JP2019115348A5 (cg-RX-API-DMAC7.html)
US9902974B2 (en) Methods and compositions for treatment of a genetic condition
DK3155099T3 (en) NUCLEASE MEDIATED DNA COLLECTION
JP2021518139A5 (cg-RX-API-DMAC7.html)
JP2021521849A5 (cg-RX-API-DMAC7.html)
JP2022516130A5 (cg-RX-API-DMAC7.html)
CN103382468B (zh) 一种水稻基因组定点改造方法
AU2018222092A1 (en) Genome editing system and method
JP2023533417A5 (cg-RX-API-DMAC7.html)
IL295858B1 (en) gRNA molecules including TRACR and crRNA, compositions containing them and their use
CN103224947A (zh) 一种基因打靶系统
JP2020521456A5 (cg-RX-API-DMAC7.html)
AU2016391970A1 (en) Compositions for linking DNA-binding domains and cleavage domains
US20190241911A1 (en) Engineered guide rna and uses thereof
CN110577971B (zh) CRISPR/Sa-SauriCas9基因编辑系统及其应用
JP2023552917A5 (cg-RX-API-DMAC7.html)
CN104560995A (zh) 一对特异识别猪H11位点的sgRNA及其编码DNA和应用
JP2020511931A5 (cg-RX-API-DMAC7.html)
WO2024158864A1 (en) Mb2cas12a variants with enhanced efficiency
CN106282230B (zh) 定点突变ldlr基因的方法